https://www.selleckchem.com/pr....oducts/icec0942-hydr
90%), while EMD-S occurred in 56 cases (36.10%). Patients with EMD-S had a significant survival disadvantage in MSS (HR = 1.844, 95% CI 1.117-3.042, = 0.017) and OS (HR = 1.853, 95% CI 1.166-2.942, = 0.009) compared to those with EMD-B. Patients with EMD interval ≤24 months were at higher risk of death than those with EMD at diagnosis in MSS (HR = 1.885, 95% CI 1.175-3.346, = 0.042) and in OS (HR = 1.33, 95% CI 1.119-2.529, = 0.036). Patients with EMD interval 24 months were at a lower risk of death as opposed to
Like
Comment
Share
